A systematic review of gemcitabine and taxanes combination therapy randomized trials for metastatic breast cancer

PURPOSE: Gemcitabine/taxanes-based combination shows anti-tumor activity for the treatment of metastatic breast cancer, but there is a debate regarding the advantages of gemcitabine and taxanes regimens as a first-line or second-line treatment for metastatic breast cancer. Here we conducted a system...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Springerplus
Autors principals: Hu, Qian, Jiang, Jun-xia, Luo, Long, Yang, Xing, Lin, Xiao, Dinglin, Xiao-xiao, Zhang, Wei, Wu, Jun-yan, Yao, He-rui
Format: Artigo
Idioma:Inglês
Publicat: Springer International Publishing 2014
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4447724/
https://ncbi.nlm.nih.gov/pubmed/26034661
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2193-1801-3-293
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars